【摘要】 目的探讨焦点解决短期治疗(SFBT)合用帕罗西汀(赛乐特)对社交恐惧症的临床疗效。方法将符合CCMD-3诊断标准的40例社交恐惧症患者,随机分为实验组(SFBT合用赛乐特)和对照组(单用赛乐特),在治疗前后及随防半年后采用社交回避及苦恼(SAD)量表评定其疗效。结果两组在疗后8周及随访半年后社交回避及苦恼(SAD)量表分比较有显著性差异。实验组评分显著低于对照组(P<0.01).两组均无严重的药物反应,因无疗效和不良反应导致的脱落率两组差异无显著性。(P>0.05)结论SFBT合用赛乐特和单用赛乐特对社交恐惧症均有疗效,且前者疗效更佳。更多还原

【Abstract】 Objective: To evaluate the effect of solution-focused brief therapy(SFBT) combined with paroxetine in treatment of social phobia.Methods: 40 paitents who met CCMD-3 criteria for social phobia were randomly assigned into experiment group(SFBT plus paroxetine,n=19)and control group(paroxetine only,n=18).Before and after treatment,and followed up for half a year,the patients were assessed three times with SAD Scale.Results:After eight weeks treatment and half a year’s follow-up,the score of SAD Scale showed significant difference.The score of SFBT group was significantly lower than that of the Paroxetine treatment group(P<0.01).Both group had no serious side effects.There was no difference in dropout rate due to less efficacy and side effects.Conclusion:SFBT combined with paroxetine and paroxetine only have significant efficacy in the treatment of social phobia,and SFBT combined with paroxetine has better effect than paroxetine alone.更多还原